Contact

All Stories

  1. New horizons for platinum-resistant ovarian cancer: insights from the 2023 American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology (ESMO) Annual Meetings

    Article • International Journal of Gynecological Cancer, December 2023, BMJ

    Khalid El Bairi

  2. The OVANORDEST project: making an impact on ovarian cancer in Morocco

    Article • International Journal of Gynecological Cancer, September 2023, BMJ

    Khalid El Bairi

  3. Distance education as a tool to improve researchers’ knowledge on predatory journals in countries with limited resources: the Moroccan experience

    Article • International Journal for Educational Integrity, January 2023, Springer Science + Business Media

    Khalid El Bairi

  4. 1326P Oncology under attack by predatory journals: A global survey

    Article • Annals of Oncology, September 2022, Elsevier

    Khalid El Bairi

  5. Exploring scientific misconduct in Morocco based on an analysis of plagiarism perception in a cohort of 1,220 researchers and students

    Article • Accountability in Research, August 2022, Taylor & Francis

    Khalid El Bairi

  6. How to critically read a meta-analysis of clinical trials in neurooncology

    Article • (IJRE) International Journal of Research and Ethics (ISSN 2665-7481), February 2022, Moroccan Association for Research and Ethics

    Khalid El Bairi

  7. FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target?

    Article • Life, January 2022, MDPI AG

    Khalid El Bairi

  8. Bevacizumab in metastatic colorectal cancer in a real-life setting – toxicity profile, survival outcomes, and impact of tumor sidedness

    Article • Współczesna Onkologia, January 2022, Termedia Sp. z.o.o.

    Khalid El Bairi

  9. Exploring the prognostic impact of tumor sidedness in ovarian cancer: A population-based survival analysis of over 10,000 patients

    Article • Cancer Treatment and Research Communications, January 2022, Elsevier

    Khalid El Bairi

  10. Practical Tools and Guidelines for Young Oncologists From Resource-Limited Settings to Publish Excellence and Advance Their Career

    Article • JCO Global Oncology, December 2021, American Society of Clinical Oncology (ASCO)

    Khalid El Bairi

  11. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    Article • npj Breast Cancer, December 2021, Springer Science + Business Media

    Khalid El Bairi

  12. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer

    Article • Biomarkers in Medicine, October 2021, Future Medicine

    Khalid El Bairi

  13. Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-Analyses

    Article • Frontiers in Oncology, September 2021, Frontiers

    Khalid El Bairi

  14. Revisiting platinum-resistant ovarian cancer: Advances in therapy, molecular biomarkers, and clinical outcomes

    Article • Seminars in Cancer Biology, September 2021, Elsevier

    Khalid El Bairi

  15. Ovarian cancer in Morocco: Time to act is now

    Article • Gynecologic Oncology Reports, August 2021, Elsevier

    Khalid El Bairi

  16. Tracing ovarian cancer research in Morocco: A bibliometric analysis

    Article • Gynecologic Oncology Reports, August 2021, Elsevier

    Khalid El Bairi

  17. The global landscape of availability, accessibility and affordability of essential diagnostics and therapeutics for the management of HER2-positive breast cancer: The ONCOLLEGE-001 survey

    Article • Journal of Cancer Policy, June 2021, Elsevier

    Khalid El Bairi

  18. The Emerging Role of Liquid Biopsy in Gastric Cancer

    Article • Journal of Clinical Medicine, May 2021, MDPI AG

    Khalid El Bairi

  19. Revisiting antibody-drug conjugates and their predictive biomarkers in platinum-resistant ovarian cancer

    Article • Seminars in Cancer Biology, April 2021, Elsevier

    Khalid El Bairi

  20. Does the “Devil” originate from the fallopian tubes?

    Article • Seminars in Cancer Biology, March 2021, Elsevier

    Khalid El Bairi

  21. Natural products in drug discovery: advances and opportunities

    Article • Nature Reviews Drug Discovery, January 2021, Springer Science + Business Media

    Khalid El Bairi, Professor Francisco Antonio Macias

  22. Cutting-Edge Technologies for Ovarian Cancer: An Overview of the Impact of Genetic Testing, Next-Generation Sequencing, and Single-Cell Analysis

    Article • January 2021, Springer Science + Business Media

    Khalid El Bairi

  23. Genetic Alterations in Ovarian Cancer as Prognostic and Predictive Biomarkers of Therapy Response and Surgical Outcomes

    Article • January 2021, Springer Science + Business Media

    Khalid El Bairi

  24. Origins and Pathology of Epithelial Ovarian Cancer: A Brief Overview

    Article • January 2021, Springer Science + Business Media

    Khalid El Bairi

  25. The Advent of Circulating Tumor DNA in the Management of Ovarian Cancer

    Article • January 2021, Springer Science + Business Media

    Khalid El Bairi

  26. The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways, and Predictive Biomarkers

    Article • January 2021, Springer Science + Business Media

    Khalid El Bairi

  27. Ovarian Cancer Biomarkers

    Article • January 2021, Springer Science + Business Media

    Khalid El Bairi

  28. Role of Her-2 in Gastrointestinal Tumours beyond Gastric Cancer: A Tool for Precision Medicine

    Article • Gastrointestinal Disorders, December 2020, MDPI AG

    Khalid El Bairi

  29. Repurposing Anticancer Drugs for the Management of COVID-19

    Article • European Journal of Cancer, September 2020, Elsevier

    Khalid El Bairi

  30. Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer?

    Article • Current Drug Targets, July 2020, Bentham Science Publishers

    Khalid El Bairi

  31. The Power of Biomarkers in Transforming Patients Care in Gynecologic Oncology

    Article • Current Drug Targets, July 2020, Bentham Science Publishers

    Khalid El Bairi

  32. Polymorphisms of Folate-Metabolizing Enzymes (MTHFR, MTR and MTRR) and Colorectal Cancer Risk: An Updated Systematic Review and Meta-analysis of Case-control Studies

    Article • June 2020, International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)

    Khalid El Bairi

  33. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

    Article • npj Breast Cancer, May 2020, Springer Science + Business Media

    Khalid El Bairi, Anna Ehinger

  34. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    Article • npj Breast Cancer, May 2020, Springer Science + Business Media

    Khalid El Bairi, Anna Ehinger

  35. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

    Article • npj Breast Cancer, May 2020, Springer Science + Business Media

    Khalid El Bairi, Anna Ehinger

  36. Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut.

    Article • Expert Review of Clinical Pharmacology, April 2020, Taylor & Francis

    Khalid El Bairi

  37. The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

    Article • The Journal of Pathology, April 2020, Wiley

    Anna Ehinger, Khalid El Bairi

  38. Colorectal Cancer Genetics: An Overview of the Actionable Building Blocks

    Article • January 2020, Springer Science + Business Media

    Khalid El Bairi

  39. Gut Microbiota, Next-Generation Sequencing, Immune-Checkpoint Inhibitors, and Colorectal Cancer: How Hot Is the Link?

    Article • January 2020, Springer Science + Business Media

    Khalid El Bairi

  40. Next-Generation Sequencing for Colorectal Cancer Management

    Article • January 2020, Springer Science + Business Media

    Khalid El Bairi

  41. Overview of Cost-Effectiveness and Limitations of Next-Generation Sequencing in Colorectal Cancer

    Article • January 2020, Springer Science + Business Media

    Khalid El Bairi

  42. The Arrival of Next-Generation Sequencing: An Overview of Current Technologies

    Article • January 2020, Springer Science + Business Media

    Khalid El Bairi

  43. The Revolution of Liquid Biopsy and Single-Cell Sequencing in the Management of Colorectal Cancer

    Article • January 2020, Springer Science + Business Media

    Khalid El Bairi

  44. Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing

    Article • January 2020, Springer Science + Business Media

    Khalid El Bairi

  45. Accessibility and affordability to trastuzumab for breast cancer patients: Voices of the global oncology community from ONCOLLEGE 001 survey, part 2

    Article • Annals of Oncology, October 2019, Elsevier

    Khalid El Bairi

  46. Painting the global picture of HER2-testing for breast cancer. The ONCOLLEGE-001 survey study

    Article • Annals of Oncology, May 2019, Elsevier

    Khalid El Bairi

  47. The arrival of predictive biomarkers for monitoring therapy response to natural compounds in cancer drug discovery

    Article • Biomedicine & Pharmacotherapy, January 2019, Elsevier

    Khalid El Bairi

  48. Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers

    Article • Cancer Medicine, May 2018, Wiley

    Khalid El Bairi

  49. Decoding colorectal cancer epigenomics

    Article • Cancer Genetics, November 2017, Elsevier

    Khalid El Bairi

  50. The Human Cancer Pathology Atlas: An open-access source for more than 900,000 Kaplan-Meier plots and 5 million cancer tissue images

    Article • Biomedicine & Pharmacotherapy, October 2017, Elsevier

    Khalid El Bairi

  51. Anticancer potential of Trigonella foenum graecum: Cellular and molecular targets

    Article • Biomedicine & Pharmacotherapy, June 2017, Elsevier

    Khalid El Bairi, Dr Mounir OUZIR, Dr Agnieszka Barbara Najda, 1 1 1 1

  52. Prediction of therapy response in ovarian cancer: Where are we now?

    Article • Critical Reviews in Clinical Laboratory Sciences, April 2017, Taylor & Francis

    Khalid El Bairi

  53. Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer

    Article • Cellular Oncology, December 2016, Springer Science + Business Media

    Khalid El Bairi

  54. Toxicological properties of fenugreek (Trigonella foenum graecum)

    Article • Food and Chemical Toxicology, October 2016, Elsevier

    Khalid El Bairi, Dr Mounir OUZIR

  55. Natural products against cancer angiogenesis

    Article • Tumor Biology, September 2016, Springer Science + Business Media

    Khalid El Bairi, Dr Agnieszka Barbara Najda, 1 1 1 1

  56. Phytochemical, organoleptic and ferric reducing properties of essential oil and ethanolic extract from Pistacia lentiscus (L.)

    Article • Asian Pacific Journal of Tropical Disease, April 2016, Elsevier

    Khalid El Bairi

  57. Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine

    Article • Biomarker Insights, January 2016, SAGE Publications

    Khalid El Bairi, Adel Gouri